Shortage reports
Actual shortage:
250 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3299 (93%)
3563
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (12%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-10-19 | 2018-11-22 | 65005 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2018-03-20 | 2019-01-18 | 43519 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2024-05-10 | 2025-03-14 | 227714 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-02-01 | 2018-09-12 | 38001 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2017-03-20 | 2017-03-24 | 3539 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2020-05-08 | 2020-06-15 | 114324 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-05-03 | 2025-01-03 | 227031 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-07-27 | 2023-08-23 | 200191 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2019-05-01 | 2019-06-17 | 82903 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-06-13 | 2025-03-07 | 230350 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-11-10 | 2024-02-02 | 209961 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-04-16 | 2018-05-22 | 46006 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2017-10-23 | 2018-01-31 | 26662 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2023-11-17 | 2024-02-02 | 210725 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2017-10-18 | 2018-01-31 | 26224 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Actual shortage | 2017-03-11 | 2018-02-21 | 537 |
| APO-VALPROIC ACID | 250MG | CAPSULE | Resolved | 2022-09-23 | 2023-05-12 | 170115 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Actual shortage | 2023-06-09 | 2024-12-05 | 194593 |
| APO-VALPROIC SYRUP | 50MG | SYRUP | Resolved | 2017-07-11 | 2017-08-18 | 15412 |
| APO-VALSARTAN | 320MG | TABLET | Resolved | 2017-03-11 | 2019-03-11 | 570 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |